These strategies combine GLP-1 receptor agonists with other active peptides, such as glucagon (GCG) or glucose-dependent insulinotropic polypeptide (GIP), to achieve greater weight reduction and metabolic benefits
Zhou J, Livak MF, Bernier M, Muller DC, Carlson OD, Elahi D, Maudsley S, Egan JM (2007) Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets
Complete digital access to quality FT journalism on any device
At Perfect B in Doral, that supervised, measured philosophy is how we approach every peptide conversation, and you can see the framework on our supervised peptide therapy program built around assessment, protocol design, and monitoring
Cell 130 , 247258 (2007)